DS
AIM

DRW Securities’s AIM ImmunoTech AIM Stock Holding History

DRW Securities’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,615
Closed -$78.6K – 1837
2025
Q4 		$78.6K Buy
69,615
+26,281
+61% +$48.6K ﹤0.01% 1088
2025
Q3 		$119K Buy
+43,334
New +$194K ﹤0.01% 1167
2024
Q2 		– Sell
-240
Closed -$11.3K – 651
2024
Q1 		$11.3K Sell
240
-10
-4% -$415 ﹤0.01% 375
2023
Q4 		$11K Sell
250
-30
-11% -$1.4K ﹤0.01% 309
2023
Q3 		$13K Sell
280
-90
-24% -$5.55K ﹤0.01% 333
2023
Q2 		$25K Buy
+370
New +$17.9K ﹤0.01% 336

Other funds holding AIM

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

DRW Securities's AIM Position: Q1 2026 in Review

DRW Securities sold out of AIM ImmunoTech (AIM) in Q1 2026, closing a stake of 69,615 shares — an estimated $78.6K sold.

DRW Securities first reported a position in AIM in Q2 2023 and held it in 6 quarters. The position peaked at $119K in Q3 2025. 18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

  • DRW Securities reported no remaining AIM ImmunoTech position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 69,615 AIM ImmunoTech shares in Q1 2026, an estimated $78.6K.
  • DRW Securities first reported a position in AIM ImmunoTech in Q2 2023 and held it in 6 quarters.
  • DRW Securities's AIM ImmunoTech position peaked at $119K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.